Theme: Recent Advancements and Developments in Endocrinology



The World’s largest gathering for Scientists. Join us the 16th International Conference on Endocrinology, Diabetes and Metabolism scheduled on October 20, 2022 Webinar. Which is mainly focuses on the “Recent Advancements and Developments in Endocrinology”. This includes relevant keynote presentations, symposia, poster presentations, speaker sessions, as well as an exposition and workshops. On behalf of the organising committee, we hope you will join us for a fantastic and pleasant gathering!

The 16th International Conference on Endocrinology, Diabetes and Metabolism brings together a unique and global combination of large and medium pharmaceutical, biotech, and analytical associations, as well as foremost universities and clinical research institutions, to share their scientific studies, encourage collaborative projects across industries and universities, and assess developing advancements around the world. With presentations on Pediatric Endocrinology, Scope of Neuroendocrinology, Reproductive Endocrinology, Effect of Physical Activity in Type 2 Diabetes, Pituitary Adenomas, Obesity and Weight Metabolism, Diabetes and Glucose Metabolism as well as other fields, Endocrinology Summit 2022 provided an opportunity to interact with and learn from professionals from all around the world.

Why to Attend?

Our main objective is to provide Diabeticians, Researchers, Scientists, Health care experts, Endocrinologists, Cardiologists, Nephrologists, students, young researchers, industrial delegates, and all others professionally involved in the study of Endocrinology, Diabetes with an opportunities to educate about the intricacies of the disease, discuss interventional procedures, examine new and modern cataract removal practises and their quality and effectiveness in the treatment of various cancers, and understand local facts and practical Endocrinologists.

Target Audience

  • Diabeticians
  • Researchers
  • Scientists
  • Health care experts
  • Endocrinologists
  • Cardiologists
  • Nephrologists
  • Nutritionists/Dieticians
  • Diabetes Health Professionals
  • Physicians
  • Nurse practitioners
  • Health care analysts
  • Doctors
  • Academic researchers
  • Professors
  • Students
  • Research Institutes
  • Business delegates
  • Young Researchers
  • Advertising and Promotion Agency Executives
  • Professionals in media sector
  • Medical colleges
  • Metabolic syndrome Societies & Associations
  • Obesity Societies & Associations
  • Diabetes Societies & Associations
  • Medical & Pharmaceutical Companies


Track 1: Covid 19 and Endocrinology

Diabetes plays a significant role in this phenotype because it is one of the most common comorbidities linked to COVID-19 severity and mortality. Careful management, including treatment changes, may be required to protect our patients from the most serious effects of COVID-19, whether they have diabetes or are hospitalised with COVID-19, as well as patients with SARS-CoV-2-induced recently onset diabetes. Obesity raises vulnerability to SARS-CoV-2 and the chance of a negative COVID-19 result.

Track 2: Diabetic Ketoacidosis

The most common acute complications of diabetes mellitus is diagnosis and management of diabetic ketoacidosis, which is a life-threatening condition if it is not treated properly. It can be seen in both Type 1 and type 2 diabetes mellitus patients. Diabetic ketoacidosis generally occurs when your body does not produce enough insulin. Diabetic ketoacidosis indications can show up rapidly and may even be your first admonition sign that you have diabetes.

Track 3: Relation of Diabetes with Endocrine System

In people with diabetes mellitus, the pancreas either does not produce any insulin or does not produce enough insulin to keep blood sugar under control. The body cannot utilise glucose as an energy source without insulin. The body must break down fat to replace the energy normally obtained from glucose, resulting in the accumulation of a poisonous byproduct known as ketones. This eventually leads to diabetic ketoacidosis, a potentially fatal illness in which excess ketones cause the blood to become overly acidic.

Track 4: Hyperprolactinemia and Hypophysitis

Hyperprolactinemia is the most well-known hypothalamic-pituitary brokenness, being a significant reason for sporadic menses and barrenness among young ladies. Prolactinoma is the most well-known reason for obsessive hyperprolactinemia. Hypophysitis is an irritation of the pituitary organ and is an uncommon reason for hypopituitarism. It very well may be essential (idiopathic) or auxiliary to sella and parasellar injuries, fundamental sicknesses, or medications (primarily resistant designated spot inhibitors). Essential hypophysitis has five histologic variations: lymphocytic, granulomatous, xanthomatous, IgG4-related, and necrotizing.

Track 5: Multiple Endocrine Neoplasia

The group of diseases  that influence the body's network of chemical delivering organs called the Various endocrine neoplasia is a endocrine neoplasia. Different endocrine neoplasia regularly includes cancers (neoplasia) in something like two endocrine organs; growths can likewise develop in different organs and tissues. These developments can be noncancerous (harmless) or destructive (threatening). Assuming the growths become dangerous, the condition can be perilous.

Track 6: Pediatric Endocrinology

Pediatric endocrinology is a medical speciality that deals with endocrine gland diseases in children, such as growth and sexual development, diabetes mellitus, and so on. Type 1 diabetes is the most frequent condition in the speciality, accounting for at least 50% of a normal clinical practise. The next most prevalent issue is growth problems, particularly those that can be treated with growth hormones.

Track 7: Scope of Neuroendocrinology

Neuroendocrinology covers a wide range of issues that are related to neuroendocrine neurons, either directly or indirectly. Neuroendocrinology is a discipline of biology that investigates the relationship between the neurological and endocrine systems, or how the brain regulates the body's hormonal activity.  To govern the physiological activities of the human body, the neurological and endocrine systems frequently work together in a process known as neuroendocrine integration. The field of neuroendocrinology developed from the discovery that the brain, particularly the hypothalamus, regulates pituitary gland hormone release, and has since grown to encompass a wide range of endocrine and neurological system linkages.

Track 8: Reproductive Endocrinology

The hormones and regulatory systems that regulate sexual development, sexual function, and reproduction are referred to as reproductive endocrinology. Infertility, hirsutism, virilization, oligomenorrhea, and amenorrhea in women, and infertility and decreased sexual function in men, can all be signs of reproductive endocrinology disorders caused by aberrant alterations anywhere in the hypothalamus–pituitary–gonadal axis.

Track 9: Effect of Physical Activity in Type 2 Diabetes

An expansion in moderate-to enthusiastic force active work (MVPA) and a reduction in stationary time (SED-time) are related with improvement in endurance and cardiovascular diseases (CVD) risk profiles in inactive patients with type 2 diabetes (T2D), as per a review in Diabetes Care. Physical activity is known to change the risk factors of diabetes.

Track 10: Pituitary Adenomas

Pituitary adenomas (PA) are a common type of endocrine neoplasia that is usually benign. PA have a high rate of clinical morbidity due to hormonal hypersecretion, neurological symptoms from cerebral mass effects or invasion of adjacent structures, and secondary hypopituitarism. Pharmacological treatment, primarily dopamine agonists (DA) and somatostatin analogues (SSA), surgery, and radiotherapy are being used to treat them [2]. Despite substantial progress in the treatment of PA, a significant portion of individuals remain uncontrollably ill. Long-term uncontrolled pituitary hormone hypersecretion, which can lead to serious systemic illnesses as well as tumour recurrence or aggressiveness, is still a difficult clinical problem.

Track 11: Obesity and Weight Metabolism

Obesity is a multifaceted, chronic, relapsing pandemic described as the abnormal or excessive accumulation of body fat caused by genetic, biochemical, microbiological, and environmental variables that promote a positive energy balance, mostly related with increased intake and decreased consumption. Overweight affects more than one-third of adults. Type 2 diabetes, heart disease, stroke, fatty liver disease, renal disease, and other health problems are all increased when you are overweight or obese. If you're having trouble losing weight, a balanced eating plan and regular physical activity may be able to help you lose weight and keep it off in the long run.

Track 12: Diabetes and Glucose Metabolism

Because of a larger ratio of body fat to muscle, overweight people with pre-diabetes or type 2 diabetes produce much more insulin than non-diabetic people. Insulin resistance is the cause of this, which means that the body's insulin isn't being used efficiently enough. As a result, it's only natural for the body to create extra insulin to compensate. The proper functioning of the metabolism in type 1 diabetes is dependent on the supply of insulin, which is normally done via injection or a pump.

Track 13: Bariatric Plastic Surgery

Bariatric surgery is a term that refers to a range of treatments that are performed on obese persons. Long-term weight loss is largely done by standard of care techniques by modifying gut hormone levels that control hunger and fullness, resulting in a new hormonal weight set point. In these operations, bariatric surgery is a hormonal surgery in which a change in gut hormones occurs as a result of the procedure's restriction and malabsorption. Long-term studies suggest that the treatments lead to considerable long-term weight loss, diabetes recovery, improvements in cardiovascular risk factors, and a mortality reduction of 40% to 23%. Obese adults with a BMI of at least 40, as well as those with a BMI of at least 35 and major comorbid medical disorders like diabetes, should consider bariatric surgery, according to the National Institutes of Health in the United States.

Endocrinology Market Size:

In the years 2021 to 2025, the global market for endocrinology medications has the potential to increase by USD 25.25 billion, with a CAGR of 6.26%. This endocrinology medications market research study offers insightful information on the market's response to COVID-19, which will aid businesses in assessing their strategic business plans. Additionally, this study goes into great detail on market segmentation by therapy area (drugs for diabetes, problems of the thyroid hormone, and others) and geography (North America, Europe, Asia, and ROW). In addition, the endocrinology medicines market research provides details on a number of industry players, such as Pharmaceuticals Corp., Beta Cell NV, Eli Lilly and Co., GlaxoSmithKline Pharma SA, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Pfizer Inc.


List of Diabetes and Endocrinology universities hospitals around the world:

  • Harvard University
  • University of Copenhagen
  • University of Oxford
  • Mayo Clinic
  • NYU Langon Hospitals
  • UCLA Medical Center
  • UCSF Medical Center
  • Royal Berkshire Hospital -Diabetes and Endocrinology
  • Edna Coates Diabetes and Endocrine Unit
  • Dr A Qureshi - Consultant Endocrinologist and in Diabetes
  • William Harvey Research Institute
  • Queen Mary University of London
  • Royal College of Physicians
  • German Diabetes Center
  • Ludwig Maximilian University of Munich
  • University of Cologne
  • Heinrich Heine University Düsseldorf
  • Heart and Diabetes Center NRW
  • Diabetes Clinic GmbH & Co. KG
  • German Diabetes Center
  • Health Plus Diabetes & Endocrinology Center
  • Endocrinologist Dubai Prime Hospital
  • GluCare Integrated Diabetes Center

Related Societies:

United States:  American Association of Clinical Endocrinology,  Christiana Care - Diabetes Prevention Resources, Care Oregon- Diabetes Care, American Association of Clinical Endocrinologists (AACE), American Association of Endocrine Surgeons, American Diabetes Association, American Society of Andrology, American Society of Endocrine Physician Assistants, American Thyroid Association, Androgen Excess and PCOS Society, Association for Program Directors in Endocrinology, Diabetes and Metabolism, Endocrine Nurses Society

Europe: European Academy of Andrology, European Biological Rhythms Society, European Calcified Tissue Society, European Network for the Study of Adrenal Tumours, European Neuroendocrine Association, Association of Endocrinologists of the Ukraine, Association Medici Endocrinology, Austrian Society for Endocrinology and Metabolism, Belarusian Association of Endocrinologists, Belgian Endocrine Society

Asia Pacific & Middle East: Pediatric Endocrine Society, Pediatric Endocrinology Nursing Society, Society for Behavioural Neuroendocrinology, Society for Gynecologic Investigation, Society for the Study of Reproduction, The Association of Program Directors in Endocrinology, Diabetes and Metabolism, The Obesity Society, The Pituitary Society, Emirates Diabetes & Endocrine Society


To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 20-20, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View